Microbot Medical® Announces First Health System in Pennsylvania to Adopt the LIBERTY® Endovascular Robotic System
Microbot Medical announced the first health system adoption of its LIBERTY Endovascular Robotic System in Pennsylvania by a globally recognized academic center, expanding its footprint in the Northeast U.S. The company now has accounts across seven states in the Eastern U.S. and recently transitioned to full market release in the second quarter, with plans to expand sales territory to the West Coast. Additionally, a recent agreement to expand access to U.S.
Key figures
- States with accounts
- 7
- Market release quarter
- Q2
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.